79347617 - INVOX

Information

• Trademark
• 79347617

• Source

• Serial Number

  79347617

• Registration Number

  7333791

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 10 - Surgical, medical, dental and veterinary apparatus and instruments, artificial limbs, eyes and teeth
  • 36 - Insurance
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  May 26, 2022
  4 years ago

• Registration Date

  March 26, 2024
  2 years ago

• Transaction Date

  May 31, 2025
  a year ago

• Status Date

  March 26, 2024
  2 years ago

• Published for Opposition Date

  January 09, 2024
  2 years ago

• Location Date

  March 26, 2024
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  BERNS, LEE-ANNE

• Attorney Docket Number

  TAW026.001IU

  Attorney Name

  Catherine J. Holland

  Law Office Assigned Location Code

  M90

• Owners

  • invoX Pharma Limited

Case File Statements

• GS0051: Pharmaceuticals for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine; Pharmaceutical preparations and substances for oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the prevention and treatment of inflammation and infectious diseases; chemical preparations for pharmaceutical purposes, namely, for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; chemical reagents for medical use; biotechnological preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; biological adjuvants for medical purposes; biochemical preparations for medical use for use in oncology, cardio-respiratory, haematology and immunity, paediatric and regenerative medicine and for the treatment of inflammation and infectious diseases; preparations for deodorizing air; medicated deodorants for health and medical purposes; oils for medical purposes; air purifying preparations, pharmaceutical preparations for inhalers; none of the aforesaid goods being disinfectants or sanitary preparations, and not being adapted for use as disinfectant or sanitisers; none of the aforesaid being goods for use in diagnostics or for use in the examination, processing, transportation or testing of veterinary or medical samples
• GS0361: Financing and equity investment services in the fields of pharmaceuticals, biotechnology life sciences; capital financing services in the fields of pharmaceuticals, biotechnology, life sciences; making direct and indirect investments, namely providing venture capital, private equity and investment funding for the development and commercialization of products and management of product portfolios in the fields of pharmaceuticals, biotechnology, life sciences; investment services, namely, asset and investment acquisition, and development services; none of the aforesaid services being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
• GS0451: Licensing of intellectual property rights; licensing of intellectual property in the field of pharmaceutical, biotechnology, life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary or medical samples; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis
• GS0101: Surgical instruments and apparatus, and medical devices, namely, inhalation devices in the field of drug delivery systems, excluding medical and veterinary sample containers, processing and analysis machines and test kits and personal protective equipment (PPE); inhalers for medical and pharmaceutical purposes; none of the aforesaid being goods for use in the examination, processing, transportation or testing of veterinary or medical samples or for use in diagnostics or in laboratory automation for diagnostic purposes, sample handling or sample preparation enabling and/or supporting medical, patient and veterinary data testing, processing and/or analysis
• GS0421: Pharmaceutical research and development in the field of biotechnology, medical devices in the field of drug delivery systems; scientific research for clinical, medical and pharmaceutical purposes in the field of biotechnology, medical devices for drug delivery systems and life sciences; scientific research and development in the field of biotechnology medical devices, life sciences and healthcare technology; pharmaceutical products development and medical device product development in the field of biotechnology, medical devices for drug delivery systems and life sciences; none of the aforesaid being in relation to the examination, processing, transportation or testing services relating to veterinary; none of the aforesaid services being in relation to diagnostic applications by means of medical samples or in the field of laboratory automation for diagnostic purposes by means of medical samples, specimen handling or sample preparation or being in the field of software and IT services for enabling and/or supporting medical, patient and veterinary sample data testing, processing and/or analysis

Case File Event Statements

• 3/16/2023 - 3 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 8/18/2022 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 8/19/2022 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 8/23/2022 - 4 years ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 3/14/2023 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/15/2023 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/4/2023 - 3 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 5/4/2023 - 3 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 5/24/2023 - 3 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 7/30/2023 - 3 years ago

  10 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 10/24/2023 - 2 years ago

  11 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME

• 11/6/2023 - 2 years ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/6/2023 - 2 years ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/7/2023 - 2 years ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 12/5/2023 - 2 years ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/8/2024 - 2 years ago

  19 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 12/20/2023 - 2 years ago

  18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 12/20/2023 - 2 years ago

  16 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/20/2023 - 2 years ago

  17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/9/2024 - 2 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 1/24/2024 - 2 years ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 1/9/2024 - 2 years ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/24/2024 - 2 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 2/13/2024 - 2 years ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 3/26/2024 - 2 years ago

  25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/26/2024 - 2 years ago

  26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 10/7/2024 - a year ago

  28 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/5/2024 - a year ago

  29 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 6/27/2024 - 2 years ago

  27 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/23/2024 - a year ago

  30 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/30/2025 - a year ago

  31 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG